00:01:50 EST Fri 05 Dec 2025
Enter Symbol
or Name
USA
CA



Hydreight Technologies Inc
Symbol NURS
Shares Issued 47,309,801
Close 2025-12-04 C$ 4.36
Market Cap C$ 206,270,732
Recent Sedar Documents

Hydreight Technologies acquisition agreements

2025-12-04 17:10 ET - Acquisition

The TSX Venture Exchange has accepted for filing the definitive transaction agreements dated Sept. 1, 2025, as amended Nov. 18, 2025, between the company and a private Texas-based limited liability company, whereby the company acquired an initial 5-per-cent membership interest (equity units) in the target company. This acquisition was structured as a subscription for newly issued equity in the target company. The consideration was the issuance of 2.25 million common shares to the target company at a deemed price of $2.30 per share, subject to a voluntary escrow.

The transaction agreements grant the company the option to acquire an up-to-40-per-cent additional equity and the right to maintain its pro rata investment interest. The option exercise is contingent on meeting quarterly prescription growth targets. The pricing for the acquisition under the option, which may be paid in cash or common shares, is determined by a mutually acceptable third party valuation.

The company will not issue more than 12 million common shares in total (excluding the initial 2.25 million shares) for both the pro rata investment right and the option. Furthermore, the company is restricted from issuing shares if, after such issuance, the target company's beneficial ownership or control would exceed 9.9 per cent of the company's issued and outstanding shares at any time. Any further consideration for the option or pro rata investment right, or any consideration exceeding the cap, remains subject to compliance with applicable exchange policies.

The transaction is arm's length in nature. The company paid a cash finder's fee of $258,750 in connection with the transaction.

For further details, please refer to the company's news releases dated July 14, 2025, Sept. 2, 2025, and Nov. 28, 2025.

© 2025 Canjex Publishing Ltd. All rights reserved.